About Epicore Biosystems
Epicore Biosystems is a company based in Cambridge (United States) founded in 2017 by Stephen Lee, Jeff Model, Alexander J Aranyosi, and Roozbeh Ghaffari.. Epicore Biosystems has raised $43.89 million across 7 funding rounds from investors including Chevron, HHS and Denka. Epicore Biosystems offers products and services including Biowearables, Gx Sweat Patch, and Sweat Analysis System. Epicore Biosystems operates in a competitive market with competitors including Polar, Nix, Mode Sensors, Healbe and Bitome, among others.
- Headquarter Cambridge, United States
- Founders Stephen Lee, Jeff Model, Alexander J Aranyosi, Roozbeh Ghaffari
-
Sectors
TechnologyHealthcare Media & Entertainment
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Epicore Biosystems, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$43.89 M (USD)
in 7 rounds
-
Latest Funding Round
$6 M (USD), Series B
May 01, 2025
-
Investors
Chevron
& 6 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Epicore Biosystems
Epicore Biosystems offers a comprehensive portfolio of products and services, including Biowearables, Gx Sweat Patch, and Sweat Analysis System. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Devices for analyzing sweat to track hydration and biomarkers.
Patch that monitors sweat for electrolyte losses in sports.
System for non-invasive biomarker collection in research.
Unlock access to complete
Unlock access to complete
Funding Insights of Epicore Biosystems
Epicore Biosystems has successfully raised a total of $43.89M across 7 strategic funding rounds. The most recent funding activity was a Series B round of $6 million completed in May 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 7
- Last Round Series B — $6.0M
-
First Round
First Round
(01 Oct 2018)
- Investors Count 7
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May, 2025 | Amount | Series B - Epicore Biosystems | Valuation |
investors |
|
| Dec, 2024 | Amount | Series B - Epicore Biosystems | Valuation | Steele Foundation for Hope |
|
| Jan, 2024 | Amount | Series A - Epicore Biosystems | Valuation | Pegasus Tech Ventures , Denka |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Epicore Biosystems
Epicore Biosystems has secured backing from 7 investors, including venture fund and institutional investors. Prominent investors backing the company include Chevron, HHS and Denka. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital investing and portfolio management services for accredited investors.
|
Founded Year | Domain | Location | |
|
Venture capital fund focused on tech sectors
|
Founded Year | Domain | Location | |
|
Venture capital fund investing in tech startups
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Epicore Biosystems
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Epicore Biosystems
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Epicore Biosystems Comparisons
Competitors of Epicore Biosystems
Epicore Biosystems operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Polar, Nix, Mode Sensors, Healbe and Bitome, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Smart sports watches for fitness tracking are provided.
|
|
| domain | founded_year | HQ Location |
Sweat-based biosensors are provided for body hydration monitoring.
|
|
| domain | founded_year | HQ Location |
Provider of hydration monitoring patch
|
|
| domain | founded_year | HQ Location |
Wristband with noninvasive glucose monitor and calorie tracker.
|
|
| domain | founded_year | HQ Location |
Wearable device that tracks hydration levels
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Epicore Biosystems
Frequently Asked Questions about Epicore Biosystems
When was Epicore Biosystems founded?
Epicore Biosystems was founded in 2017 and raised its 1st funding round 1 year after it was founded.
Where is Epicore Biosystems located?
Epicore Biosystems is headquartered in Cambridge, United States. It is registered at Cambridge, Massachusetts, United States.
Who is the current CEO of Epicore Biosystems?
Roozbeh Ghaffari is the current CEO of Epicore Biosystems. They have also founded this company.
Is Epicore Biosystems a funded company?
Epicore Biosystems is a funded company, having raised a total of $43.89M across 7 funding rounds to date. The company's 1st funding round was a Series A of $1.54M, raised on Oct 01, 2018.
What does Epicore Biosystems do?
Epicore Biosystems was founded in 2017 in Cambridge, United States, within the biotech and wearables sector. A proprietary sweat microfluidic sensing platform, designed to be skin-like, is offered for analyzing small sweat droplets directly from the skin. Real-time data visualization is enabled through a companion mobile application. Applications span sports teams, military research labs, and clinical studies, with operations focused on sensor development and integration.
Who are the top competitors of Epicore Biosystems?
Epicore Biosystems's top competitors include Nix, Polar and Mode Sensors.
What products or services does Epicore Biosystems offer?
Epicore Biosystems offers Biowearables, Gx Sweat Patch, and Sweat Analysis System.
Who are Epicore Biosystems's investors?
Epicore Biosystems has 7 investors. Key investors include Chevron, HHS, Denka, Alumni Ventures, and Joyance Partners.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.